ConductScience.org, home

Gene · 11255

Drugs17

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ABT-288CHEMBL3545029Histamine H3 receptor antagonistANTAGONISTChEMBL
BAVISANTCHEMBL2103862Histamine H3 receptor antagonistANTAGONISTChEMBL
BETAHISTINECHEMBL24441Histamine H3 receptor antagonistANTAGONISTChEMBL
CIPRALISANTCHEMBL278462Histamine H3 receptor agonistAGONISTChEMBL
CIPRALISANT MALEATECHEMBL2106003Histamine H3 receptor agonistAGONISTChEMBL
GSK-1004723CHEMBL1767164Histamine H3 receptor antagonistANTAGONISTChEMBL
GSK189254CHEMBL517140Histamine H3 receptor antagonistANTAGONISTChEMBL
GSK239512CHEMBL3092650Histamine H3 receptor antagonistANTAGONISTChEMBL
IRDABISANTCHEMBL1829335Histamine H3 receptor antagonistANTAGONISTChEMBL
JNJ-17216498CHEMBL3545030Histamine H3 receptor antagonistANTAGONISTChEMBL
JNJ-39220675CHEMBL1171754Histamine H3 receptor antagonistANTAGONISTChEMBL
MK-0249CHEMBL476323Histamine H3 receptor inverse agonistINVERSE AGONISTChEMBL
PF-03654746CHEMBL2151197Histamine H3 receptor antagonistANTAGONISTChEMBL
PF-03654764CHEMBL2206292Histamine H3 receptor antagonistANTAGONISTChEMBL
PITOLISANTCHEMBL462605Histamine H3 receptor inverse agonistINVERSE AGONISTChEMBL
PITOLISANT HYDROCHLORIDECHEMBL4164059Histamine H3 receptor inverse agonistINVERSE AGONISTChEMBL
SUVN-G3031CHEMBL4297328Histamine H3 receptor inverse agonistINVERSE AGONISTChEMBL

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/11255/drugs